| abstract |
Compounds, compositions and methods for modulating the expression of C-reactive protein are provided. The composition comprises an oligonucleotide that targets a nucleic acid encoding a C-reactive protein. Methods of using these compounds for the modulation of C-reactive protein expression and the diagnosis and treatment of diseases associated with C-reactive protein expression are provided. |